Anti-glycation effect of gold nanoparticles on collagen

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 2, 2012, Pages 260-264

  Kim, Ji Hoon ^a   Hong, Chung Oui ^a   Koo, Yun Chang ^a   Choi, Hee Don ^b   Lee, Kwang Won ^a  

^a Korea University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Aging; Collagen; Dermis; Glycation; Gold nanoparticle

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN; DIGLYCOALDEHYDE; GOLD NANOPARTICLE;

ANTIGLYCATION EFFECT; ARTICLE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DERMIS; DRUG ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; PARTICLE SIZE; PROTEIN ANALYSIS;

COLLAGEN; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GOLD; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES;

EID: 84863078915     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.260     Document Type: Article

References (30)

1. Pageon H. Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model. Pathol. Biol. (Paris), 58, 226-231 (2010).
2. Tan AL, Forbes JM, Cooper ME. AGE, RAGE, and ROS in diabetic nephropathy. Semin. Nephrol., 27, 130-143 (2007).
3. Thorpe SR, Baynes JW. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging, 9, 69-77 (1996).
4. Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol. Med., 6, 114-125 (2000).
5. Hirose J, Yamabe S, Takada K, Okamoto N, Nagai R, Mizuta H. Immunohistochemical distribution of advanced glycation end products (AGEs) in human osteoarthritic cartilage. Acta Histochem., 113, 613-618 (2011).
6. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science, 232, 1629-1632 (1986).
7. Jeon KI, Byun MS, Jue DM. Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit. Exp. Mol. Med., 35, 61-66 (2003).
8. Kim NH, Lee MY, Park SJ, Choi JS, Oh MK, Kim IS. Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3. Immunology, 122, 607-614 (2007).
9. Norton S. A brief history of potable gold. Mol. Interv., 8, 120-123 (2008).
10. Barathmanikanth S, Kalishwaralal K, Sriram M, Pandian SR, Youn HS, Eom S, Gurunathan S. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J. Nanobiotechnol., 8, 16-30 (2010).
11. Guo R, Song Y, Wang G, Murray RW. Does core size matter in the kinetics of ligand exchanges of monolayer-protected Au clusters? J. Am. Chem. Soc., 127, 2752-2757 (2005).
12. Storhoff JJ, Elghanian R, Mucic RC, Mirkin CA, Letsinger RL. One-pot colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticle probes. J. Am. Chem. Soc., 120, 1959-1964 (1998).
13. Grabar KC, Freeman RG, Hommer MB, Natan MJ. Preparation and characterization of Au colloid monolayers. Anal. Chem., 67, 735-743 (1995).
14. Ghoshmoulick R, Bhattacharya J, Mitra CK, Basak S, Dasgupta AK. Protein seeding of gold nanoparticles and mechanism of glycation sensing. Nanomedicine, 3, 208-214 (2007).
15. Rahbar S, Yerneni KK, Scott S, Gonzales N, Lalezari I. Novel inhibitors of advanced glycation endproducts (part II). Mol. Cell Biol. Res. Commun., 3, 360-366 (2000).
16. Pageon H, Bakala H, Monnier VM, Asselineau D. Collagen glycation triggers the formation of aged skin in vitro. Eur. J. Dermatol., 17, 12-20 (2007).
17. Delgado-Andrade C, Seiquer I, Navarro MP, Morales FJ. Maillard reaction indicators in diets usually consumed by adolescent population. Mol. Nutr. Food Res., 51, 341-351 (2007).
18. Pageon H, Técher MP, Asselineau D. Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules. Exp. Gerontol., 43, 584-588 (2008).
19. Thomas KG, Kamat PV. Making gold nanoparticles glow: Enhanced emission from a surface-bound fluoroprobe. J. Am. Chem. Soc., 122, 2655-2656 (2000).
20. Kreibig U, Vollmer M. Optical Properties of Metal Clusters. Vol. 25, Springer, Berlin, 1995.
21. Pelizzetti E, Pelizzetti E. Fine Particles Science and Technology: From Micro to Nanoparticles. Kluwer Academic Publishers, Dordrecht (1996).
22. Link S, El-Sayed MA. Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles. J. Phys. Chem. B, 103, 4212-4217 (1999).
23. Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys., 419, 31-40 (2003).
24. Singha S, Bhattacharya J, Datta H, Dasgupta AK. Anti-glycation activity of gold nanoparticles. Nanomed-Nanotechnol., 5, 21-29 (2009).
25. ε-(carboxymethyl)lysine in foods and related systems. Ann. N.Y. Acad. Sci., 1126, 20-24 (2008).
26. Svobodova A, Walterova D, Vostalova J. Ultraviolet light induced alteration to the skin. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 150, 25-38 (2006).
27. Monnier VM, Kohn RR, Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A., 81, 583-587 (1984).
28. Yakimovich NO, Ezhevskii AA, Guseinov DV, Smirnova LA, Gracheva TA, Klychkov KS. Antioxidant properties of gold nanoparticles studied by ESR spectroscopy. Russ. Chem. Bull., Int. Ed., 57, 520-523 (2008).
29. Alikhani Z, Alikhani M, Boyd CM, Nagao K, Trackman PC, Graves DT. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J. Biol. Chem., 280, 12087-12095 (2005).
30. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, Bijlsma JW, Lafeber FP, Baynes JW, TeKoppele JM. Effect of collagen turnover on the accumulation of advanced glycation end products. J. Biol. Chem., 275, 39027-39031 (2000).